Evidence map›Paper›PMID 21107515›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2011

Cell cloning-based transcriptome analysis in cyclin-dependent kinase-like 5 mutation patients with severe epileptic encephalopathy.

Juliette Nectoux, Yann Fichou, Nicolas Cagnard, Nadia Bahi-Buisson, Patrick Nusbaum, Franck Letourneur, Jamel Chelly, Thierry Bienvenu

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02705677 completednot on this mapstarted 2017, after this paper: background citation

Biobanking of Rett Syndrome and Related Disorders Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2017 to 2021Enrolled752ConditionsRett Syndrome, MECP2 Duplication, CDKL5, FOXG1 Disorders
NCT02738281 completednot on this mapstarted 2015, after this paper: background citation

Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2015 to 2021Enrolled1,044ConditionsRett Syndrome, MECP2 Duplication dIsorder, CDKL5 Disorder, FOXG1 Syndrome
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Juliette NectouxCNRS UMR 8104, Institut Cochin, Université Paris Descartes, Paris, France.
Yann Fichou
Nicolas Cagnard
Nadia Bahi-Buisson
Patrick Nusbaum
Franck Letourneur
Jamel Chelly
Thierry Bienvenu
Hôpital Cochin · FRInstitut Cochin · FRCentre National de la Recherche Scientifique · FRHôpital Necker-Enfants Malades · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the human CDKL5 gene have been shown to cause infantile spasms, as well as Rett syndrome-like phenotype. Because CDKL5 is subjected to X chromosome inactivation (XCI), individual cells from CDKL5 mutation girls either express the wild-type or mutant allele, likely resulting in different consequences at both the cellular and molecular levels. To identify these consequences, we carried out gene expression profiling on clonal populations derived from primary cultures of three patients' fibroblasts either expressing the wild-type or mutant allele. A total of 16 up-regulated and 20 down-regulated genes were identified. The differentially expressed gene products, mostly involved in differentiation and oxidative stress may be related to a mechanism underlying mental retardation and epilepsy. Among these, the apoptosis signal-regulated kinase MAP3K5 expression was found to be altered in non-neuronal, but also in neuronal CDKL5-deficient cells. Due to the fact that MAP3K5 activates MAP kinase pathway, which mediates signals leading to both differentiation and survival in neuronal cells, we suggest that a CDKL5 deficit may induce changes in synaptic plasticity in the patient's brain.

Indexed as

Gene Expression ProfilingBrainClone CellsCluster AnalysisFemaleFibroblastsGene Expression RegulationGenotypeHumansInfantIntellectual DisabilityLennox Gastaut SyndromeMAP Kinase Kinase Kinase 5MutationOrgan SpecificityProtein Serine-Threonine KinasesCDKL5 protein, humanMAP3K5 protein, humanMAP Kinase Kinase Kinase 5Protein Serine-Threonine Kinases

Identifiers

PMID21107515
OpenAlexW2150673612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.